Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):e50-2. doi: 10.1097/QAI.0000000000000134.

Authors

Nadia K Landolt¹, Nittaya Phanuphak, Sasiwimol Ubolyam, Suteeraporn Pinyakorn, Stephen Kerr, Jennisa Ahluwalia, Parawee Thongpaeng, Narukjaporn Thammajaruk, Serge Cremers, Tiffany Thomas, Surasith Chaithongwongwatthana, Joep M A Lange, Jintanat Ananworanich

Affiliation

¹ *The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), Bangkok, Thailand †The Thai Red Cross AIDS Research Centre, Bangkok, Thailand ‡SEARCH, Bangkok, Thailand §The Kirby Institute, The University of New South Wales, Sydney, Australia ‖Irving Institute for Clinical and Translation, Research Biomarkers Core Laboratory, Columbia University Medical Center, New York, NY ¶Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand #Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.

PMID: 24608892
DOI: 10.1097/QAI.0000000000000134

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Alkynes
Anti-HIV Agents / administration & dosage*
Anti-HIV Agents / blood
Benzoxazines / administration & dosage*
Benzoxazines / blood
Contraceptive Agents, Female / administration & dosage
Contraceptive Agents, Female / blood
Cyclopropanes
Desogestrel / administration & dosage*
Desogestrel / blood
Dose-Response Relationship, Drug
Drug Interactions
Ethinyl Estradiol / administration & dosage*
Ethinyl Estradiol / blood
Female
HIV Infections / drug therapy*
Humans
Nevirapine / administration & dosage*
Nevirapine / blood
Prospective Studies

Substances

Alkynes
Anti-HIV Agents
Benzoxazines
Contraceptive Agents, Female
Cyclopropanes
etonogestrel
Ethinyl Estradiol
Desogestrel
Nevirapine
efavirenz